Massoud Alibakhsh is a serial tech entrepreneur with a background in electrical engineering and computer science. He's currently the co-founder and CEO of Omadeus which is a unique AI technology company focused on the next AI revolution to make software intelligent. He founded Medicat in 1994 which to this day is the leading provider of healthcare systems in the academic market. From 2000 to 2018 he was the founder, CEO, and chief architect for one of the first cloud-based medical practice management and electronic health record systems marketed under the NueMD brand. NueMD was a small offshoot startup that survived the dot-com era and grew significantly and was acquired in 2018. Today it is part of Global Payment Network, a Fortune 500 company. Mr. Alibakhsh also holds a number of technology and software patents. His latest work is on a new architecture for deep integration of AI with traditional software applications to make software truly intelligent.
As we embark on this extraordinary journey into the boundless realms of artificial intelligence, our mission is to navigate the ever-expanding landscapes of intelligence, innovation, and technological marvels. The panel serves as our guiding compass, pointing towards a future where AI not only transforms industries but also reshapes the very fabric of our existence.
Join us on this exhilarating expedition as we delve into the forefront of AI advancements, unlocking new dimensions and charting territories previously unexplored. From cutting-edge research to real-world applications, our collective pursuit is to understand, adapt, and thrive in the dynamic and evolving landscape of artificial intelligence. Together, let's navigate this exciting odyssey, where the future unfolds before us with limitless possibilities.